SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-158670
Filing Date
2017-05-04
Accepted
2017-05-04 16:07:58
Documents
53
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d156134d10q.htm 10-Q 561081
2 EX-31.1 d156134dex311.htm EX-31.1 6750
3 EX-31.2 d156134dex312.htm EX-31.2 6769
4 EX-32.1 d156134dex321.htm EX-32.1 4118
5 EX-32.2 d156134dex322.htm EX-32.2 4066
  Complete submission text file 0001193125-17-158670.txt   2723986

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT kpti-20170331.xml EX-101.INS 418651
7 XBRL TAXONOMY EXTENSION SCHEMA kpti-20170331.xsd EX-101.SCH 32672
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kpti-20170331_cal.xml EX-101.CAL 46566
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kpti-20170331_def.xml EX-101.DEF 111330
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE kpti-20170331_lab.xml EX-101.LAB 291695
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kpti-20170331_pre.xml EX-101.PRE 197666
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36167 | Film No.: 17813959
SIC: 2834 Pharmaceutical Preparations